Skip to main content
Fig. 6 | Arthritis Research & Therapy

Fig. 6

From: Interleukin (IL)-25 suppresses IL-22-induced osteoclastogenesis in rheumatoid arthritis via STAT3 and p38 MAPK/IκBα pathway

Fig. 6

The effect of IL-25 in RANKL-induced osteoclast differentiation from peripheral blood monocytes. CD14+ monocytes were pre-treated with IL-25 (0, 10, 50, 100 ng/ml) for 4 h, and then cultured with 25 ng/ml of M-CSF and 1 ng/ml RANKL. a TRAP+ multinucleated cell count and pit area were measured. b The gene expression of TRAP, NFATc1, cathepsin K, OC-STAMP, and ATP6v0d2 from differentiated osteoclasts was measured by real-time PCR. Data were normalized to beta-actin and reported in relative expression units. *P < 0.05, **P < 0.01, and ***P < 0.001

Back to article page
\